117 related articles for article (PubMed ID: 2438051)
1. Differentiation of an Abelson virus-transformed immature B precursor cell line under the expression of tyrosine kinase activity of v-abl oncogene product.
Maeda T; Owada MK; Sugiyama H; Miyake S; Tani Y; Ogawa H; Oka Y; Komori T; Soma T; Kishimoto S
Cell Differ; 1987 Apr; 20(4):263-9. PubMed ID: 2438051
[TBL] [Abstract][Full Text] [Related]
2. Protein phosphorylation at tyrosine residues in v-abl transformed mouse lymphocytes and fibroblasts.
Saggioro D; Ferracini R; Di Renzo MF; Naldini L; Chieco-Bianchi L; Comoglio PM
Int J Cancer; 1986 Apr; 37(4):623-8. PubMed ID: 2420727
[TBL] [Abstract][Full Text] [Related]
3. Activation of the abl oncogene and its involvement in chromosomal translocations in human leukemia.
Rosson D; Reddy EP
Mutat Res; 1988 May; 195(3):231-43. PubMed ID: 3129652
[TBL] [Abstract][Full Text] [Related]
4. Viral oncogene expression during differentiation of Abelson virus-infected murine promonocytic leukemia cells.
Hines DL
Cancer Res; 1988 Apr; 48(7):1702-7. PubMed ID: 2832050
[TBL] [Abstract][Full Text] [Related]
5. An active v-abl protein tyrosine kinase blocks immunoglobulin light-chain gene rearrangement.
Chen YY; Wang LC; Huang MS; Rosenberg N
Genes Dev; 1994 Mar; 8(6):688-97. PubMed ID: 7926759
[TBL] [Abstract][Full Text] [Related]
6. bcr/abl and src but not myc and ras replace v-abl in lymphoid transformation.
Engelman A; Rosenberg N
Mol Cell Biol; 1990 Aug; 10(8):4365-9. PubMed ID: 2164639
[TBL] [Abstract][Full Text] [Related]
7. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.
Kamps MP; Sefton BM
Oncogene Res; 1988 Sep; 3(2):105-15. PubMed ID: 2465525
[TBL] [Abstract][Full Text] [Related]
8. Unlinked regulation of cell growth and differentiation in immature B cell lines.
Oka Y; Sugiyama H; Tsukada S; Inoue H; Hakura A; Kishimoto S
Cell Immunol; 1990 Oct; 130(1):42-9. PubMed ID: 2118832
[TBL] [Abstract][Full Text] [Related]
9. IL-7 reconstitutes multiple aspects of v-Abl-mediated signaling.
Banerjee A; Rothman P
J Immunol; 1998 Nov; 161(9):4611-7. PubMed ID: 9794389
[TBL] [Abstract][Full Text] [Related]
10. A small molecule Abl kinase inhibitor induces differentiation of Abelson virus-transformed pre-B cell lines.
Muljo SA; Schlissel MS
Nat Immunol; 2003 Jan; 4(1):31-7. PubMed ID: 12469118
[TBL] [Abstract][Full Text] [Related]
11. Abelson-transformed fibroblasts contain nuclear phosphotyrosyl-proteins which preferentially bind to murine DNA.
Bell JC; Mahadevan LC; Colledge WH; Frackelton AR; Sargent MG; Foulkes JG
Nature; 1987 Feb 5-11; 325(6104):552-4. PubMed ID: 2433597
[TBL] [Abstract][Full Text] [Related]
12. Functional V region formation during in vitro culture of a murine immature B precursor cell line.
Sugiyama H; Akira S; Kikutani H; Kishimoto S; Yamamura Y; Kishimoto T
Nature; 1983 Jun; 303(5920):812-5. PubMed ID: 6408480
[TBL] [Abstract][Full Text] [Related]
13. Structures and activities of activated abl oncogenes.
Risser R; Holland GD
Curr Top Microbiol Immunol; 1989; 147():129-53. PubMed ID: 2695292
[No Abstract] [Full Text] [Related]
14. Lymphoid cells transformed by Abelson virus require the v-abl protein-tyrosine kinase only during early G1.
Chen YY; Rosenberg N
Proc Natl Acad Sci U S A; 1992 Aug; 89(15):6683-7. PubMed ID: 1379715
[TBL] [Abstract][Full Text] [Related]
15. The transgenic window on lymphoid malignancy.
Adams JM; Harris AW; Vaux DL; Alexander WS; Rosenbaum H; Klinken SP; Strasser A; Bath ML; McNeall J; Cory S
Princess Takamatsu Symp; 1989; 20():297-309. PubMed ID: 2518688
[TBL] [Abstract][Full Text] [Related]
16. The v-abl tyrosine kinase negatively regulates NF-kappa B/Rel factors and blocks kappa gene transcription in pre-B lymphocytes.
Klug CA; Gerety SJ; Shah PC; Chen YY; Rice NR; Rosenberg N; Singh H
Genes Dev; 1994 Mar; 8(6):678-87. PubMed ID: 7926758
[TBL] [Abstract][Full Text] [Related]
17. Structure and expression of germ line immunoglobulin gamma 2b transcripts.
Lutzker S; Alt FW
Mol Cell Biol; 1988 Apr; 8(4):1849-52. PubMed ID: 3132612
[TBL] [Abstract][Full Text] [Related]
18. An E mu-v-abl transgene elicits plasmacytomas in concert with an activated myc gene.
Rosenbaum H; Harris AW; Bath ML; McNeall J; Webb E; Adams JM; Cory S
EMBO J; 1990 Mar; 9(3):897-905. PubMed ID: 2155783
[TBL] [Abstract][Full Text] [Related]
19. In vitro transformation of murine pro-B and pre-B cells by v-mpl, a truncated form of a cytokine receptor.
Fichelson S; Vigon I; Dusanter I; Charon M; Velu T; Baillou C; Gisselbrecht S; Lemoine FM
J Immunol; 1995 Feb; 154(4):1577-86. PubMed ID: 7836743
[TBL] [Abstract][Full Text] [Related]
20. A human immunoglobulin gene reduces the incidence of lymphomas in c-Myc-bearing transgenic mice.
Nussenzweig MC; Schmidt EV; Shaw AC; Sinn E; Campos-Torres J; Mathey-Prevot B; Pattengale PK; Leder P
Nature; 1988 Dec; 336(6198):446-50. PubMed ID: 3143076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
